Published date: 5 September 2016
This notice was replaced on 5 September 2016
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 23 January 2017)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Diagnostics and radiodiagnostic devices and supplies - 33124000
Medical consumables - 33140000
Reagents and contrast media - 33696000
Laboratory services - 71900000
Location of contract
Any region
Value of contract
£4,000,000
Procurement reference
NHSBT0834
Published date
5 September 2016
Closing date
5 October 2016
Contract start date
9 February 2017
Contract end date
31 December 2020
Contract type
Service contract
Procedure type
Open procedure
Any interested supplier may submit a tender in response to an opportunity notice.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
NHS Blood and Transplant is a Special Health Authority, responsible for the provision of blood components and tissues and a range of associated specialist laboratory and patient therapeutic services to hospitals in England. The Authority operates at a local level through a network of Blood Centres but is structured nationally for managerial control with a single management team under its own Chief Executive Officer. The Authority has two testing sites throughout England, collecting approximately 1.7 million blood and platelet donations and approximately 8,000 tissue donations each year. Within the Manufacturing and Logistics directorate of the Authority, the testing function performs a wide range of testing services; these include the large-scale molecular and serological screening of blood, tissue and stem cell donations for a range of infectious agents.
The Authority requires a fully integrated microbiology managed equipment service for Hepatitis E virus (HEV) ribonucleic acid (RNA) NAT Testing. This includes the assay, fully automated equipment, consumables and data management software required to send final results to the Authority's information management system. Tenderers are required to respond on the basis of offering a fully automated system which can meet the Requirements as set out in the Specification. The Authority's current contractual arrangements for HEV NAT Testing expire on 31st January 2017. The Authority requires the successful Tenderer's system to be fully implemented, validated and carrying out testing at both of the Authority's sites no later than three months after contract award.
More information
Attachments
-
- 20160826_NHSBT0834 - ITT Guidance v2-Final-CF.doc
- NHSBT0834 - ITT Guidance
-
- 20160826_NHSBT0834_Specification-v5-Final-CF.xls
- NHSBT0834 - Specification
About the buyer
Address
500 North Bristol Park
North Way, Filton
Bristol
BS34 7QH
England
Share this notice
All content is available under the
